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        Introduction 
  Cell interactions in the nervous system depend on multiple cues 
acting sequentially or in parallel. Adhesion molecules initiate 
recognition of the extracellular matrix and other cells, and, as 
transmembrane receptors, activate intracellular signaling cas-
cades fundamental to all aspects of cell behavior. This line of 
communication is important not only during ontogenetic devel-
opment but also in the adult nervous system during functional 
changes, such as learning, memory, and regeneration after trau-
matic injury. The neural cell adhesion molecule (NCAM) has 
been recognized as an important mediator of cell interactions 
via its extracellular domain, which consists of immunoglobulin-
like and fi  bronectin type III  –  homologous structures that act as 
ligand and receptors in homophilic and heterophilic cell inter-
actions. Two of the major isoforms of NCAM with molecular 
masses of 180 kD (NCAM180) and 140 kD (NCAM140) are 
transmembrane glycoproteins that trigger signaling cascades in 
the cell interior when clustered either by their natural ligands or 
by antibodies (  Schuch et al., 1989  ; for review see   Maness and 
Schachner, 2007  ). Signaling cascades triggered by NCAM have 
been implicated in neurite outgrowth, neuronal survival, and 
synaptic plasticity (  Rutishauser et al., 1988  ;   L  ü  thi et al., 1994  ; 
  Bukalo et al., 2004  ;   Walmod et al., 2004  ). 
  The most well-described intracellular signaling pathways 
activated by NCAM to induce neurite outgrowth and neuronal 
differentiation include activation of PKC with subsequent NCAM-
dependent redistribution of the enzyme to cholesterol-enriched 
plasma membrane microdomains, so-called lipid rafts, where 
PKC activates GAP43 (  Leshchyns  ’  ka et al., 2003  ;   Korshunova 
et al., 2007  ). Association of PKC with NCAM depends on the 
FGF receptor (  Leshchyns  ’  ka et al., 2003  ), which associates with 
NCAM and is activated in response to NCAM clustering at the 
cell surface (  Niethammer et al., 2002  ;   Kiselyov et al., 2005  ). 
  R
eceptor protein tyrosine phosphatase      (RPTP    ) 
phosphatase activity is required for intracellular sig-
naling cascades that are activated in motile cells and 
growing neurites. Little is known, however, about mecha-
nisms that coordinate RPTP     activity with cell behavior. 
We show that clustering of neural cell adhesion molecule 
(NCAM) at the cell surface is coupled to an increase in 
serine phosphorylation and phosphatase activity of RPTP   . 
NCAM associates with T- and L-type voltage-dependent 
Ca 
2+   channels, and NCAM clustering at the cell surface 
results in Ca 
2+   inﬂ  ux via these channels and activation of 
NCAM-associated calmodulin-dependent protein kinase 
II     (CaMKII    ). Clustering of NCAM promotes its redistri-
bution to lipid rafts and the formation of a NCAM  –  RPTP      –
  CaMKII     complex, resulting in serine phosphorylation of 
RPTP     by CaMKII    . Overexpression of RPTP     with mu-
tated Ser180 and Ser204 interferes with NCAM-induced 
neurite outgrowth, which indicates that neurite extension 
depends on NCAM-induced up-regulation of RPTP     activity. 
Thus, we reveal a novel function for a cell adhesion mol-
ecule in coordination of cell behavior with intracellular 
phosphatase activity.
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(RPTP    ) by direct interaction (  Bodrikov et al., 2005  ). When 
NCAM is clustered at the neuronal cell surface, the NCAM140  –
 RPTP    complex is further stabilized by the membrane  –  cytoskel-
eton linker protein spectrin and redistributes to lipid rafts, where 
RPTP     binds to and activates fyn (  Bodrikov et al., 2005  ). 
  We now present evidence that clustering of NCAM at the 
cell surface results in an enhancement of serine phosphoryla-
tion and phosphatase activity of RPTP    . By investigating the 
mechanisms of NCAM-dependent RPTP     activation, we found 
that PKC    , which had been shown in other studies to mediate 
activation of RPTP     (  Brandt et al., 2003  ), is not involved in 
NCAM-induced activation. Instead, we identifi  ed calmodulin 
  Another pathway includes activation of p59fyn (hereafter 
referred to as fyn)/FAK (  Beggs et al., 1994  ,   1997  ) being induced 
in response to NCAM clustering or via binding of the glial cell 
line  –  derived neurotrophic factor (GDNF) to NCAM (  Paratcha 
et al., 2003  ). Activation of this pathway depends on NCAM  ’  s as-
sociation with glycosylphosphatidylinositol (GPI)-anchored pro-
teins, such as prion protein ( Santuccione et al., 2005 ) and GFR  1, 
a cognate receptor for GDNF (  Paratcha et al., 2003  ), and palmi-
toylation of the intracellular domain of NCAM (  Niethammer et al., 
2002  ), linking NCAM to p59fyn enriched in lipid rafts. We have 
previously found that this pathway is induced by NCAM140, 
which associates with the receptor protein tyrosine phosphatase    
  Figure 1.       NCAM140 clustering induces phosphorylation of RPTP     on Ser180 and Ser204 and enhances the phosphatase activity of RPTP    .   (A) Graph 
shows phosphatase activity of RPTP     from NCAM+/+ and NCAM    /     brain lysates. (B  –  D) RPTP     immunoprecipitates were probed by Western blotting 
with antibodies against RPTP     and phospho serines (B and C) or subjected to serine phosphorylation estimation by the alkaline hydrolysis (D). Note that 
similar levels of RPTP     were immunoprecipitated from NCAM+/+ and NCAM    /     brain lysates (B). Mock immunoprecipitation with nonspeciﬁ  c IgG 
served as a control. Phosphatase activity and serine phosphorylation of RPTP     are reduced in NCAM    /     brains. Graph in C shows quantitation of the 
blots in B with optical density for NCAM+/+ brains set to 100%. In A and D, mean values of phosphatase activity (A) or phosphate released by alkaline 
(D) in RPTP     immunoprecipitates from NCAM+/+ brains were set to 100%. (E) RPTP    -negative ﬁ  broblasts transfected with RPTP    WT alone or cotransfected 
with NCAM140 and RPTP    WT, RPTP    S180A, RPTP    S204A, or RPTP    S180/204A were treated with NCAM polyclonal antibodies or nonspeciﬁ  c rabbit 
IgG. Note that similar levels of NCAM140 were expressed in cells (lysates) and that similar levels of RPTP     were immunoprecipitated from the lysates (IP: 
HA-tag). Mutation of Ser180 and/or Ser204 does not inﬂ  uence coimmunoprecipitation of NCAM140 with RPTP    . Immunoprecipitated RPTP     was then 
subjected to the serine phosphorylation estimation by the alkaline hydrolysis (top) and phosphatase activity analysis (bottom). Application of NCAM anti-
bodies but not IgG increased serine phosphorylation and phosphatase activity of RPTP    WT in NCAM140  –  RPTP    WT  –  cotransfected cells. Phosphorylation 
and activation of RPTP     mutants were inhibited. Mean values of phosphate released by alkaline (top) or phosphatase activity (bottom) in RPTP     immuno-
precipitates from IgG-treated NCAM140  –  RPTP    WT  –  cotransfected cells were set to 100%. Mean values   ±   SEM are shown (A and D,   n     ≥   8; C,   n   = 6; 
E,   n     ≥   6). *, P   <   0.05 (paired   t   test).     1187  NCAM ACTIVATES RPTP     VIA CAMKII       • Bodrikov et al. 
phosphatase activity of RPTP     from NCAM   /    brains was 
reduced by   55% when compared with RPTP   from NCAM+/+ 
brains (  Fig. 1 A  ). 
  Because the phosphatase activity of RPTP     is regulated 
by phosphorylation, we analyzed phosphorylation of RPTP     by 
probing RPTP     immunoprecipitates with antibodies against phos-
phorylated serine residues by Western blotting. In addition, we 
estimated levels of phosphate released from serine residues of the 
immunoprecipitated RPTP     by alkaline treatment. Both meth-
ods showed that serine phosphorylation of RPTP     was reduced 
in NCAM   /    brains by    60%  ( Fig.  1,  B – D ). 
  Phosphorylation of Ser180 and Ser204 within RPTP     in-
tracellular domain has been shown to be critical for the induction 
of RPTP     phosphatase activity (  Stetak et al., 2001  ;   Zheng et al., 
2002 ).  To  analyze the role of Ser180 and Ser204 in NCAM-medi-
ated RPTP     regulation, an HA tag containing wild-type RPTP    
(RPTP   WT) and RPTP   mutants with Ser180 (RPTP  S180A), 
Ser204 (RPTP    S204A), or both (RPTP   S180/204A)  substi-
tuted with alanine were coexpressed with NCAM140 in RPTP  -
defi  cient fi  broblasts. Similar levels of NCAM140 coimmuno-
precipitated with RPTP    WT and RPTP     mutants from lysates 
of transfected cells (  Fig. 1 E  ). Thus, mutation of Ser180 and 
Ser204 does not affect the binding of RPTP     to NCAM. Clus-
tering of NCAM140 at the surface of fi  broblasts by NCAM anti-
bodies increased levels of serine phosphorylation of RPTP   WT 
by   200% ( Fig. 1 E ). In contrast, phosphorylation of RPTP  S180A 
(CaM)-dependent protein kinase II   (CaMKII  ) as a previously 
unrecognized enzyme to bind to and phosphorylate RPTP    
at two serine residues that increase the phosphatase activity of 
RPTP    . We show that clustering of NCAM at the cell surface 
induces lipid raft  –  dependent activation of CaMKII    , which then 
phosphorylates RPTP     at the two serine residues, which, in turn, 
leads to activation of fyn. Overexpression of RPTP     mutated in 
both serine residues interferes with NCAM-induced neurite out-
growth of hippocampal neurons in vitro. These observations at-
tribute an important role in the trifunctional interaction between 
NCAM, CaMKII    , and RPTP     in lipid rafts and thus add a new 
dimension in NCAM-mediated signaling pathways. 
  Results 
  NCAM up-regulates RPTP     activity 
by increasing its phosphorylation 
on Ser180 and Ser204 
  To analyze the role of NCAM in regulation of the phosphatase ac-
tivity of RPTP  , RPTP   was immunoprecipitated from NCAM+/+ 
and NCAM   /    brain lysates. We then used two commercially 
available phosphotyrosine-containing peptides derived from the 
epidermal growth factor receptor, which serve as substrates for 
many protein tyrosine phosphatases, and estimated the effi  ciency 
of the release of phosphate from these peptides in the presence 
of RPTP     immunoprecipitates. This analysis showed that the 
  Figure 2.       PKC     associates with NCAM and 
RPTP     but its activity is not regulated by 
NCAM.   (A and B) PKC     (A) or NCAM (B) 
immunoprecipitates (IP) from NCAM+/+ brain 
lysates were analyzed by Western blotting 
as indicated. Mock immunoprecipitation with 
nonspeciﬁ  c IgG (A) or from NCAM    /     brain 
lysates (B) served as a control. RPTP     and 
NCAM120 coimmunoprecipitate with PKC    , 
and PKC     coimmunoprecipitates with NCAM. 
BH, brain homogenate. (C and D) NCAM+/+ 
and NCAM    /     brain homogenates (C) and 
RPTP     immunoprecipitates from NCAM+/+ 
and NCAM    /     brain lysates (D) were probed 
by Western blotting with antibodies against 
total PKC     and active Thr505-phosphorylated 
PKC    . Note the similar loading (GAPDH label-
ing in C) and immunoprecipitation efﬁ  ciency 
(RPTP     labeling in D). Total levels of active PKC     
and levels of active PKC     associated with RPTP     
are not changed in NCAM    /     brains.     JCB • VOLUME 182 • NUMBER 6 • 2008  1188
Hence, NCAM140 is the major NCAM isoform involved in regu-
lation of RPTP     activity. 
  NCAM does not regulate PKC     activity 
and its association with RPTP     
  Previous studies indicated that among all PKC isoforms, only 
PKC     phosphorylates RPTP     on Ser180 and Ser204 in nonneu-
ronal cells (  den Hertog et al., 1995  ;   Tracy et al., 1995  ;   Zheng et al., 
2002  ;   Brandt et al., 2003  ). NCAM associates with and induces 
activation of several PKC isoforms (  Leshchyns  ’  ka et al., 2003  ; 
  Kolkova et al., 2005  ), but its role in PKC     activation has not been 
analyzed. We thus analyzed whether NCAM regulates RPTP    
phosphorylation by inducing PKC   activation. RPTP   coimmuno-
precipitated with PKC     (  Fig. 2 A  ), and PKC     coimmunoprecipi-
tated with NCAM (  Fig. 2 B  ) from brain lysates. However, levels of 
activated PKC     phosphorylated at Thr505 in the activation loop of 
the kinase were not changed in NCAM   /    brain homogenates 
and RPTP    S180/204A in response to NCAM140 clustering was 
blocked, whereas phosphorylation of RPTP    S204A was par-
tially inhibited (  Fig. 1 E  ). Hence, Ser180 and Ser204 are phos-
phorylated in response to NCAM140 clustering, with Ser180 
being required for NCAM-dependent RPTP     phosphorylation. 
  Phosphatase activity of RPTP    WT was increased after 
NCAM140 clustering by     250% (  Fig. 1 E  ). Phosphatase activ-
ity of RPTP     mutants, however, was reduced when compared 
with RPTP    WT. Mutation of Ser180 induced a stronger in-
hibitory effect on the catalytic activity of RPTP     when com-
pared with Ser204 (  Fig. 1 E  ). The catalytic activity of RPTP    
was fully inhibited when both Ser180 and Ser204 were mutated 
( Fig. 1 E ). In contrast to fi  broblasts transfected with NCAM140, 
application of NCAM antibodies to the fi  broblasts cotransfected 
with RPTP    WT and NCAM180 or NCAM120 did not result in 
phosphorylation and activation of RPTP    WT (Fig. S1, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200803045/DC1). 
  Figure 3.       NCAM promotes CaMKII     activa-
tion and RPTP      –  CaMKII     complex formation.   
(A) RPTP     immunoprecipitates (IP) from 
NCAM+/+ and NCAM    /     brain lysates 
were probed by Western blotting with antibod-
ies against CaMKII    . Note that similar levels of 
RPTP     were immunoprecipitated. Mock immuno-
precipitation with nonspeciﬁ   c IgG served as 
control. Coimmunoprecipitation of CaMKII     
with RPTP     is reduced in NCAM    /     brain 
lysates. (B) NCAM+/+ and NCAM    /     brain 
homogenates were probed by Western blot-
ting with antibodies against total and active 
Thr286-phosphorylated CaMKII     and GAPDH 
(loading control). The levels of active CaMKII     
were reduced in NCAM    /     brain homoge-
nates. Graphs show quantitation of the blots 
(mean   ±   SEM,   n   = 6 for A and B) with optical 
density for NCAM+/+ probes set to 100%. 
*, P   <   0.05, paired   t   test. (C) NCAM was clus-
tered at the cell surface of cultured hippocam-
pal neurons by NCAM antibodies (H28live). 
Neurons were then ﬁ   xed and colabeled with 
antibodies against RPTP     and CaMKII    . A 
high-magniﬁ  cation image of a neurite is shown. 
NCAM clusters overlap with accumulations 
of RPTP     and CaMKII     (arrows). Bar, 5   μ  m. 
(D) CaMKII     immunoprecipitates from NCAM+/+ 
and NCAM    /     brain lysates were probed by 
Western blotting with antibodies against NCAM. 
NCAM140 and NCAM180 coimmunoprecipi-
tated with CaMKII    . Mock immunoprecipitation 
with nonspeciﬁ  c IgG served as a control.     1189  NCAM ACTIVATES RPTP     VIA CAMKII       • Bodrikov et al. 
tated with RPTP     from brain lysates (  Fig. 3 A  ). Interestingly, 
binding of CaMKII   to RPTP   was reduced in NCAM  /   brains 
( Fig. 3 A ). Levels of activated Thr286-phosphorylated CaMKII   
were also reduced in NCAM   /    brains (  Fig. 3 B  ). Hence, 
NCAM regulates CaMKII     activation and RPTP    – CaMKII   
complex formation. 
  In agreement, in cultured hippocampal neurons maintained 
in vitro for 24 h, CaMKII     accumulated in growth cones of the 
growing neurites, where distributions of CaMKII     and NCAM 
partially overlapped (see   Fig. 7 B  ). Clustering of NCAM at the cell 
surface of neurites with NCAM antibodies applied to live neurons 
induced partial redistribution of RPTP   to NCAM clusters ( Fig. 3 C ; 
  Bodrikov et al., 2005  ). Overlapping accumulations of NCAM and 
RPTP    also colocalized with CaMKII   aggregates ( Fig. 3 C ). Thus, 
CaMKII     is a likely candidate involved in NCAM140-induced 
RPTP     phosphorylation accompanying NCAM clustering. 
(  Fig. 2 C  ). Furthermore, similar levels of activated PKC     co-
immunoprecipitated with RPTP   from NCAM+/+ and NCAM  /   
brain lysates ( Fig. 2 D ). Thus, NCAM does not regulate association 
of RPTP     with PKC    , nor does it regulate PKC     activation in 
the brain. In agreement, the most prominent NCAM isoform that 
coimmunoprecipitated with PKC     was the smallest GPI-linked 
NCAM isoform with a molecular mass of 120 kD (NCAM120; 
  Fig. 2 A  ). NCAM120 lacks the intracellular domain and therefore 
probably associates indirectly with PKC    , as has been shown for 
spectrin, another intracellular binding partner of NCAM120 that 
associates with NCAM120 via lipids (  Leshchyns  ’  ka et al., 2003  ). 
  NCAM induces RPTP     phosphorylation 
by activating CaMKII     
 CaMKII    is another serine/threonine protein kinase that associates 
with NCAM (  Sytnyk et al., 2006  ). CaMKII     coimmunoprecipi-
  Figure 4.       RPTP     is phosphorylated by CaMKII     on Ser180 and Ser204.   (A) Recombinant RPTP    -ID-GST or GST coupled to beads were incubated with 
CaMKII    . The gel stained with Coomassie blue shows that approximately equal amounts of RPTP    -ID-GST and GST were bound to beads. The beads, treated 
and nontreated with CaMKII    , were then subjected to the analysis of serine phosphorylation by alkaline hydrolysis (bottom left) or phosphatase activity (bottom 
right). Values for GST were subtracted as background, and values of serine phosphorylation (bottom left) or phosphatase activity (bottom right) for RPTP    -ID-
GST not treated with CaMKII     were set to 100%. (B) RPTP     from NCAM    /     brain lysates was incubated with CaMKII     in the presence or absence of KN62 
and Bis1. RPTP     was then subjected to the analysis of serine phosphorylation by alkaline hydrolysis. Values of phosphate released by alkaline from RPTP     not 
treated with CaMKII     were set to 100%. (C) RPTP     immunoprecipitated from lysates of RPTP    -negative ﬁ  broblasts transfected with RPTP    WT, RPTP    S180A, 
RPTP    S204A, or RPTP    S180/204A was incubated with CaMKII    . The immunoprecipitates, treated and untreated with CaMKII    , were then subjected to the 
analysis of serine phosphorylation by alkaline hydrolysis (left) or phosphatase activity (right). Mean values of serine phosphorylation (left) or phosphatase activ-
ity (right) of RPTP    WT not treated with CaMKII     were set to 100%. Mean values   ±   SEM are shown (A,   n   = 6; B,   n   = 11; C,   n   = 9). *, P   <   0.05 (paired   t   test).     JCB • VOLUME 182 • NUMBER 6 • 2008  1190
  Figure 5.       CaMKII     activity is required for NCAM140-induced fyn activation.   (A and B) CHO cells were cotransfected with NCAM140 and RPTP    WT 
and treated with nonspeciﬁ  c rabbit IgG or NCAM polyclonal antibodies in the absence or presence of KN62. RPTP     and fyn immunoprecipitates from the 
lysates of these cells were then probed with phosphoserine antibodies (A) or antibodies against activated Tyr531-dephosphorylated fyn (B) by Western blot-
ting. Note that similar levels of RPTP     and fyn were immunoprecipitated in all groups. KN62 inhibited serine phosphorylation of RPTP     and activation of fyn 
in response to NCAM antibodies. Graphs show quantitation of the blots (mean   ±   SEM), with the levels in cells treated with nonspeciﬁ  c IgG without KN62 
set to 100%. (C) Representative images of neurites of cultured hippocampal neurons treated with nonspeciﬁ  c rat IgG or NCAM monoclonal antibodies 
(H28live) in the presence or absence of KN62 and labeled with antibodies against activated Tyr416-phosphorylated fyn by indirect immunoﬂ  uorescence. 
Inverted immunoﬂ  uorescence images are shown to accentuate the differences in labeling intensities. Note the higher levels of activated fyn along neurites 
of NCAM antibody-treated neurons and the inhibition of this effect by KN62. Bar, 10   μ  m. (D and E) Graphs show mean levels   ±   SEM in arbitrary units of 
active Tyr416-phosphorylated (D) or Tyr531-dephosphorylated (E) fyn along neurites of hippocampal neurons treated with nonspeciﬁ  c rat IgG or NCAM 
monoclonal antibodies (H28live, D), or Fc or NCAM-Fc (E) in the absence or presence of KN62.   n     >   90 neurites from 45 neurons from 3 coverslips 1191  NCAM ACTIVATES RPTP     VIA CAMKII       • Bodrikov et al. 
analyzed in each group (for D and E). (F) Cultured cortical neurons were treated with nonspeciﬁ  c rabbit IgG or NCAM polyclonal antibodies in the absence 
or presence of BisI and KN62. Lysates of these cells and fyn immunoprecipitates from the lysates were then probed with the indicated antibodies by Western 
blotting. Note that KN62 but not BisI inhibited fyn and CaMKII     activation in response to NCAM antibodies. Graphs show quantitation of the blots (mean   ±   
SEM) with the levels in cells treated, with nonspeciﬁ  c IgG without inhibitors set to 100%. *, P   <   0.05 (paired   t   test).     
 
  In agreement with this idea, NCAM140 coimmunopre-
cipitated with CaMKII     from brain lysates (  Fig. 3 D  ). NCAM180 
also coimmunoprecipitated with CaMKII     (  Fig. 3 D  ), in accor-
dance with our previously published data (  Sytnyk et al., 2006  ). 
It is interesting in this respect that clustering of NCAM140 in-
duced activation of both CaMKII     and RPTP     (  Figs. 1   and S2, 
available at http://www.jcb.org/cgi/content/full/jcb.200803045/
DC1), whereas clustering of NCAM180 induced activation of 
CaMKII     but not RPTP     (Figs. S1 and S2). The intracellu-
lar domain of NCAM140 binds to the intracellular domain of 
RPTP     with higher affi  nity than the intracellular domain of 
NCAM180 in in vitro binding assays (  Bodrikov et al., 2005  ). 
Furthermore, only NCAM140 but not NCAM180 associates 
with RPTP     in transfected CHO cells (  Bodrikov et al., 2005  ). 
Collectively, previous observations and our new data suggest 
that the tight association of NCAM140 with RPTP     is required 
for CaMKII    -mediated serine phosphorylation of RPTP   . 
  CaMKII     phosphorylates the intracellular 
domain of RPTP     and increases its 
phosphatase activity 
  To directly analyze the CaMKII    -mediated serine phosphoryla-
tion of RPTP    , recombinant intracellular domains of RPTP    
(RPTP    -ID) were used in an in vitro phosphorylation assay: 
incubation of RPTP    -ID with recombinant CaMKII     resulted 
in a pronounced increase in serine phosphorylation and phos-
phatase activity of RPTP   -ID  ( Fig.  4 A ). 
  Next, we verifi  ed whether CaMKII     also phosphorylates 
endogenous full-length RPTP  , which was immunopurifi  ed from 
NCAM   /    brain lysates to assure that serine phosphorylation 
of RPTP     was not saturated. Incubation of RPTP     with recom-
binant CaMKII     resulted in RPTP     phosphorylation (  Fig. 4 B  ). 
Similarly, RPTP     was phosphorylated by CaMKII     immuno-
purifi  ed from rat brain and used instead of recombinant CaMKII   
(unpublished data). Bisindolylmaleimide I (BisI), an inhibitor 
of PKC isozymes, among them PKC    , had no effect on RPTP    
phosphorylation in these experiments (  Fig. 4 B  ), which ex-
cluded the possibility that RPTP   was phosphorylated by PKC   
copurifi  ed with RPTP     from brain lysates. Phosphorylation of 
RPTP     by recombinant CaMKII     was blocked in the presence 
of KN62, an inhibitor of CaMKII     (  Fig. 4 B  ). 
  To analyze the sites of CaMKII   -mediated  phosphory-
lation, RPTP    WT and RPTP   S180A,  RPTP  S204A,  and 
RPTP    S180/204A mutants were transfected into RPTP   -negative 
fi  broblasts. Transfected proteins were then immunoisolated from 
cell lysates and incubated with recombinant CaMKII   .  Incubation 
with CaMKII     resulted in an approximately sixfold increase in 
serine phosphorylation of RPTP  WT, whereas CaMKII  -mediated 
serine phosphorylation of RPTP    S180A and RPTP   S204A  was 
reduced and serine phosphorylation of RPTP   S180/204A  was 
fully blocked (  Fig. 4 C  ). The levels of serine phosphorylation 
of RPTP     induced by CaMKII     correlated with the levels of 
RPTP     phosphatase activity after incubation with CaMKII   : 
the highest increase in the phosphatase activity was observed for 
RPTP    WT, being lower for RPTP    S180A and RPTP   S204A, 
whereas it was not detectable for RPTP    S180/204A (  Fig. 4 C  ). 
Interestingly, mutation of Ser180 had a more profound effect on 
CaMKII    -induced serine phosphorylation and phosphatase 
activity of RPTP     than the Ser204 mutation (  Fig. 4 C  ), which 
correlates with the effect of these mutations on NCAM-induced 
RPTP     phosphorylation (  Fig. 1  ). We conclude that CaMKII    
phosphorylates RPTP     at Ser180 and Ser204. 
  CaMKII     is required for NCAM-induced 
fyn activation 
 To  confi  rm that NCAM140-induced serine phosphorylation of 
RPTP     is mediated by CaMKII     in live cells, CHO cells were 
cotransfected with NCAM140 and RPTP    WT and treated with 
NCAM antibodies in the absence or presence of the CaMKII    
inhibitor KN62. Application of NCAM antibodies strongly in-
creased serine phosphorylation of RPTP    WT in transfected 
cells, as measured by Western blotting with phosphoserine-spe-
cifi  c antibodies (  Fig. 5 A  ). NCAM-dependent serine phospho-
rylation of RPTP    WT was inhibited by KN62 (  Fig. 5 A  ), which 
indicates that CaMKII     activation is required for NCAM-
induced RPTP     phosphorylation. 
 Because  RPTP    is the major phosphatase that induces fyn 
activation in NCAM-activated signaling (  Bodrikov et al., 2005  ), 
we analyzed whether CaMKII     activity is required for fyn acti-
vation in response to NCAM clustering at the cell surface. 
Application of NCAM antibodies to CHO cells cotransfected with 
NCAM140 and RPTP    WT increased levels of Tyr531-dephos-
phorylated and thus activated fyn in these cells, as measured by 
Western blot analysis (  Fig. 5 B  ). NCAM-induced fyn activation 
was completely inhibited by KN62 (  Fig. 5 B  ). 
  Similarly, KN62 inhibited fyn activation in response to ap-
plication of NCAM antibodies or NCAM-Fc to cultured neurons 
as shown by immunofl  uorescence labeling or Western blot anal-
ysis of active fyn with antibodies specifi  c for Tyr531-dephos-
phorylated or Tyr416-autophosphorylated fyn (  Fig. 5, C  –  F  ). The 
PKC     inhibitor BisI had no effect on NCAM-induced fyn acti-
vation (  Fig. 5 F  ). Thus, we conclude that CaMKII     activity is 
required for NCAM-induced RPTP    -mediated fyn activation. 
  Association of NCAM with lipid 
rafts is required for NCAM-induced 
CaMKII     activation 
  Clustering of NCAM140 and NCAM180 induces their redistribu-
tion to lipid rafts (  Niethammer et al., 2002  ;   Leshchyns  ’  ka et al., 
2003  ;   Bodrikov et al., 2005  ;   Santuccione et al., 2005  ). Therefore, 
we analyzed whether lipid rafts play a role in NCAM-induced 
CaMKII     activation. In cultured hippocampal neurons extracted 
with cold 1% Triton X-100 and colabeled with antibodies against 
Thr286-phosphorylated CaMKII     and the lipid raft marker PI(4,5)JCB • VOLUME 182 • NUMBER 6 • 2008  1192
NCAM at the cell surface with NCAM antibodies resulted in 
an approximately threefold increase in the levels of detergent-
insoluble active CaMKII     and a higher overlap in distribution 
of CaMKII     and PI(4,5)P2 along neurites when compared with 
P2 ( Niethammer et al., 2002 ), accumulations of activated CaMKII   
partially overlapped with the clusters of PI(4,5)P2 ( Fig. 6 A ), which 
indicates that cytoskeleton- and/or lipid raft  –  associated detergent-
insoluble pools of CaMKII   were present in neurites. Clustering of 
  Figure 6.       Association of NCAM140 with lipid rafts is required for CaMKII     activation.   (A, left) Representative images of neurites of cultured hippocampal 
neurons treated with nonspeciﬁ  c rabbit IgG or NCAM polyclonal antibodies, extracted in cold 1% Triton X-100, and labeled with antibodies against acti-
vated Thr286-phosphorylated CaMKII     and PI(4,5)P2 by indirect immunoﬂ  uorescence. Note the higher levels of activated CaMKII     and the higher degree 
of colocalization of activated CaMKII     with PI(4,5)P  2   along neurites of NCAM antibody-treated neurons. Arrows show clusters of activated CaMKII     co-
localizing with PI(4,5)P  2   accumulations. Bar, 10   μ  m. (right) Graphs show mean levels   ±   SEM in arbitrary units (AU) of active Thr286-phosphorylated CaMKII     
(top) and coefﬁ  cients of correlation between distributions of Thr286 phosphorylated CaMKII     and PI(4,5)P  2   (bottom) along neurites.   n     >   90 neurites from 
45 neurons from 3 coverslips analyzed in each group. (B) Brain homogenates (BH), cytosolic fraction (CF), total membrane fraction (MF), and lipid raft frac-
tion (RF) from NCAM+/+ and NCAM    /     brains were probed by Western blotting with antibodies against activated Thr286 phosphorylated CaMKII    , 
total CaMKII    , T- and L-type VDCC, lipid raft marker fyn, the soluble protein marker GAPDH, and the membrane protein marker CHL1. Note the accumula-
tion of activated CaMKII     in lipid rafts. (C) Lysates of CHO cells cotransfected with RPTP    WT and NCAM140, NCAM140    cys, or GFP and treated with 
nonspeciﬁ  c rabbit IgG or NCAM polyclonal antibodies were probed with antibodies against NCAM, activated Thr286-phosphorylated CaMKII    , and 
total CaMKII    . Note the similar levels of expression of NCAM140 and NCAM140    cys but the reduced activation of CaMKII     in NCAM140    cys- versus 
NCAM140-transfected cells. The graph shows quantitation of the blots with the levels of activated CaMKII     in GFP-transfected cells treated with nonspeciﬁ  c 
IgG set to 100%. (D) RPTP     was immunoprecipitated from cell lysates in C, and serine phosphorylation of RPTP     was analyzed by alkaline hydrolysis. The 
amount of phosphate released by alkaline hydrolysis from RPTP     from cells transfected with GFP instead of NCAM and treated with nonspeciﬁ  c IgG was 
set to 100%. For C and D, mean values   ±   SEM are shown (  n   = 6). *, P   <   0.05 (paired   t   test).     1193  NCAM ACTIVATES RPTP     VIA CAMKII       • Bodrikov et al. 
neurons treated with nonspecifi  c immunoglobulins ( Fig. 6 A ). This 
observation suggests that activation of CaMKII     in response to 
NCAM clustering occurs in lipid rafts. 
  In agreement, Western blot analysis of the cytosolic, total 
membrane, and lipid raft fractions isolated from the brain tissue of 
young mice showed that activated CaMKII     accumulated in lipid 
rafts (  Fig. 6 B  ). In contrast, total CaMKII     protein was broadly 
distributed in all fractions (  Fig. 6 B  ). Importantly, levels of acti-
vated CaMKII     but not total CaMKII     protein, fyn, or glycer-
aldehyde-3-phosphate dehydrogenase (GAPDH) were reduced 
in the cytosolic fraction and lipid rafts from NCAM   /    versus 
NCAM+/+ brains (  Figs. 6 B   and S3, available at http://www.jcb
.org/cgi/content/full/jcb.200803045/DC1), which indicates that 
NCAM is implicated in the activation of CaMKII     that accumu-
lates in lipid rafts and/or redistributes to the soluble pool. 
  To analyze whether redistribution of NCAM to lipid rafts is 
required for CaMKII     activation and RPTP     phosphorylation, 
CHO cells were cotransfected with RPTP    WT and NCAM140 
or NCAM140    Cys, an NCAM140 mutant with inactivated 
palmitoylation sites within its intracellular domain that blocks its 
association with lipid rafts (  Niethammer et al., 2002  ). Applica-
tion of NCAM antibodies to NCAM140-transfected cells resulted 
in a pronounced increase in the levels of activated CaMKII    
and serine phosphorylation of RPTP    WT in these cells (  Fig. 6, 
C and D  ). Although expression levels of NCAM140   Cys  were 
similar to those of NCAM140, application of NCAM antibodies 
did not infl  uence levels of activated CaMKII     and phospho-
rylated RPTP    WT in NCAM140    Cys-transfected cells nor in 
GFP-transfected cells used as a negative control (  Fig. 6, C and D  ). 
NCAM140-dependent CaMKII     activation and RPTP     phos-
phorylation and activation were also blocked in CHO cells 
treated with methyl-    -cyclodextrin (Fig. S3), an agent that binds 
to cholesterol, thereby destroying the integrity of lipid rafts 
( Niethammer et al., 2002 ). Thus, association of NCAM with lipid 
rafts is required for NCAM-dependent CaMKII     activation and 
RPTP     phosphorylation. 
  NCAM associates with T- and L-type 
voltage-dependent Ca 
2+   channels (VDCC) 
 CaMKII    activation depends on an increase in cytosolic Ca 
2+  
that binds to CaM. Binding of Ca 
2+  -CaM to the regulatory domain 
of the kinase activates the kinase by releasing the catalytic do-
main from inhibition by autoregulatory sequences proximal to the 
CaM binding site. NCAM clustering at the cell surface has been 
shown to be accompanied by an increase in Ca 
2+   concentration 
in the cytosol, with the VDCC of the T and, to a lower extent, 
L type playing a major role in NCAM-dependent Ca 
2+   infl  ux to 
the cell (  Schuch et al., 1989  ;   Kiryushko et al., 2006  ). T- and 
L-type VDCC were present at high levels in lipid rafts from 
brain tissue (  Fig. 6 B  ), thus they are well poised to provide Ca 
2+   for 
  Figure 7.       NCAM associates with T- and L-type VDCC.   (A) NCAM immuno-
precipitates (IP) from NCAM+/+ brain lysates were analyzed by Western 
blotting with antibodies against NCAM and T- and L-type VDCC. Mock 
immunoprecipitation with nonspeciﬁ  c IgG served as control. Brain homo-
genate (BH) is shown for comparison. T- and L-type VDCC coimmunopre-
cipitate with NCAM. (B) A growth cone of a cultured hippocampal neuron 
colabeled with antibodies against NCAM, CaMKII    , and T-type VDCC 
is shown. Note the colocalization of these three proteins in ﬁ  lopodia. 
(C) NCAM was clustered at the surface of cultured hippocampal neurons with 
NCAM monoclonal antibodies (H28live), and neurons were colabeled 
with antibodies against CaMKII     and T-type VDCC. A representative neu-
rite is shown. Note that clusters of NCAM overlap with accumulations of 
T-type VDCC and CaMKII     (arrows). Bars, 5   μ  m.     
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  Figure 8.       NCAM-induced CaMKII     activation depends on Ca 
2+   inﬂ  ux via T- and L-type VDCC.   (A) Cultured hippocampal neurons were incubated with pimoz-
ide and nifedipine, inhibitors of T-and L-type VDCC, respectively. Neurons were then stimulated with rat NCAM monoclonal antibodies (H28live) or nonspeciﬁ  c 
rat IgG, then ﬁ  xed and colabeled with antibodies against activated Thr286-phosphorylated CaMKII    . Representative images are shown. Note that clustering 
of NCAM without inhibitors induces an increase in active CaMKII     levels along neurites and that active CaMKII     accumulates in NCAM clusters. Pimozide 
and nifedipine inhibit CaMKII     activation. Graph shows mean levels   ±   SEM in arbitrary units (AU) of active CaMKII     along neurites.   n     >   45 neurites from 30 
neurons from 3 coverslips analyzed in each group. Bar, 20   μ  m. (B) Cultured cortical neurons were treated with nonspeciﬁ  c rabbit IgG or NCAM polyclonal 
antibodies in the absence or presence of pimozide and nifedipine. Lysates of these cells and fyn immunoprecipitates from the lysates were then probed with the 
indicated antibodies by Western blotting. Note that pimozide and nifedipine inhibited fyn and CaMKII     activation in response to NCAM antibodies. Graphs 
show quantitation of the blots (mean   ±   SEM), with the levels in cells treated with nonspeciﬁ  c IgG without inhibitors set to 100%. *, P   <   0.05 (paired   t   test).     1195  NCAM ACTIVATES RPTP     VIA CAMKII       • Bodrikov et al. 
CaMKII     activation in response to NCAM redistribution to 
lipid rafts. Moreover, T- and L-type VDCC associated with NCAM 
in the brain, as shown by coimmunoprecipitation of these VDCC 
with NCAM from brain lysates (  Fig. 7 A  ). Although L-type 
VDCC are known to accumulate in growth cones being involved 
in cytoskeleton rearrangements (  Ohbayashi et al., 1998  ), much 
less is known about T-type VDCC. Colabeling of cultured hip-
pocampal neurons with antibodies against NCAM, T-type VDCC, 
and CaMKII     showed that all three proteins accumulated in 
growth cones and, in particular, growth cone fi  lopodia (  Fig. 7 B  ). 
When NCAM was clustered at the neuronal surface with NCAM 
antibodies, T-type VDCC and CaMKII   accumulated in NCAM 
clusters along neurites (  Fig. 7 C  ). Thus, we hypothesize that clus-
tering of NCAM at the growth cones induces formation of the 
NCAM – T-  and  L-type VDCC – CaMKII    complex, thereby link-
ing CaMKII     to the Ca 
2+   source. 
  NCAM-induced CaMKII     activation depends 
on Ca 
2+   inﬂ  ux via T- and L-type VDCC 
  Next, we verifi  ed the role of T- and L-type VDCC in NCAM-
dependent CaMKII   activation. In cultured hippocampal neurons, 
clustering of NCAM at the neuronal surface induced an    80% 
increase in the levels of activated Thr286-phosphorylated 
CaMKII    along neurites, as shown by immunocytochemical anal-
ysis (  Fig. 8 A  ). Pimozide, a T-type VDCC inhibitor, completely 
blocked this effect (  Fig. 8 A  ). Nifedipine, an L-type VDCC inhibi-
tor, also inhibited NCAM-dependent CaMKII     activation, al-
though with a slightly lower effi  ciency than pimozide (  Fig. 8 A  ). 
  Similarly, pimozide and nifedipine inhibited NCAM-
dependent CaMKII     activation in cultured cortical neurons ana-
lyzed by Western blotting (  Fig. 8 B  ). Importantly, pimozide and 
nifedipine also blocked NCAM-dependent dephosphorylation 
of fyn at Tyr531 (  Fig. 8 B  ). Hence, we conclude that NCAM 
induces Ca 
2+   infl  ux via T- and L-type VDCC for CaMKII     acti-
vation, which results in up-regulation of the phosphatase activ-
ity of RPTP     and fyn dephosphorylation and activation. 
  Phosphorylation of RPTP     on Ser180 and 
Ser204 is required for NCAM-mediated 
neurite outgrowth 
  In neurons exposed to NCAM-Fc in the culture medium (  Fig. 9 A  ) 
or seeded on top of NCAM-transfected fi  broblasts (  Williams 
et al., 1995  ), the KN62 inhibitor of CaMKII     abolished the 
NCAM-dependent increase in neurite outgrowth over the base-
line level of nonstimulated neurons, which indicates that CaMKII    
activity is required for NCAM-mediated neurite outgrowth. 
  To analyze whether CaMKII   -dependent  RPTP    phos-
phorylation on Ser180 and/or Ser204 is required for NCAM-
mediated neurite outgrowth, cultured neurons were transfected 
with GFP or cotransfected with GFP and RPTP  WT or the RPTP    
mutants RPTP   S180A,  RPTP   S204A, or RPTP   S180/204A. 
These mutations within RPTP   did not affect binding of RPTP   
to NCAM (  Fig. 1  ). Hence, RPTP     mutants overexpressed in 
neurons should act in a dominant-negative fashion by substitut-
ing for endogenous RPTP     in the NCAM  –  RPTP     complex. 
Overexpression of RPTP    WT in neurons resulted in enhanced 
neurite outgrowth most likely caused by the nonspecifi  c outgrowth-
promoting activation of Src-family kinases by RPTP   WT 
(  Fig. 9 B  ). Exposure of GFP-transfected neurons to NCAM-Fc 
applied in the culture medium increased neurite lengths by   100% 
when compared with Fc-treated GFP-transfected control neu-
rons (  Fig. 9 B  ). A similar,     100% increase in neurite length was 
observed for NCAM-Fc  –  versus Fc-treated RPTP   WT-transfected 
neurons (  Fig. 9 B  ). However, neurites in NCAM-Fc  –  treated 
RPTP    WT-transfected neurons were approximately two times 
longer than in NCAM-Fc  –  treated GFP-transfected neurons, which 
indicates that RPTP    WT potentiates the response to NCAM-Fc 
(  Fig. 9 B  ). RPTP    S180A and RPTP    S204A mutants showed a 
reduced ability to promote neurite outgrowth and to enhance 
responsiveness to NCAM-Fc when compared with RPTP   WT 
(  Fig. 9 B  ). The RPTP    S180A mutant was strongly impaired in 
its ability to nonspecifi  cally promote neurite outgrowth but did 
not completely block the response to NCAM-Fc. In contrast, 
the RPTP    S204A mutant strongly interfered with the response 
to NCAM-Fc but was still able to nonspecifi  cally promote neu-
rite outgrowth at a level that was not different from that of 
RPTP    WT. A plausible explanation for this observation is that 
Ser180 and Ser204 may play slightly distinct roles in the main-
tenance of the unregulated basal versus the NCAM-mediated, thus 
  Figure 9.       NCAM-induced phosphorylation of RPTP     on Ser180 and 
Ser204 is required for NCAM-mediated neurite outgrowth.   (A) Cultured 
hippocampal neurons were treated with Fc or NCAM-Fc in the presence or 
absence of KN62. Graph shows mean lengths of neurites   ±   SEM normal-
ized to the mean neurite length in neurons treated with Fc in the absence 
of KN62 (  n     >   200). Note that KN62 inhibits NCAM-dependent neurite 
outgrowth. (B) Cultured hippocampal neurons were transfected with GFP 
alone or cotransfected with GFP and RPTP    WT or RPTP     mutants and 
treated with Fc or NCAM-Fc. Graph shows mean lengths of neurites   ±   SEM 
normalized to the mean neurite length in Fc-treated GFP-transfected neurons 
(  n     >   150). Note that RPTP    WT promotes neurite outgrowth and potentiates 
the response to NCAM-Fc. Mutation in either Ser180 or Ser204 inhibits 
the outgrowth-promoting effect of RPTP    , whereas the RPTP    S180/204A 
mutant functions as a dominant-negative construct that fully blocks NCAM-
dependent neurite outgrowth. *, P   <   0.05 (  t   test).     JCB • VOLUME 182 • NUMBER 6 • 2008  1196
  Figure 10.       A schematic model of molecular interactions induced by NCAM140 clustering and resulting in fyn activation.   (A) Nonclustered NCAM140 
resides outside of lipid rafts and does not associate with RPTP    , CaMKII     (shown as a holoenzyme), and fyn, which are present in inactive forms in the 
plasma membrane outside of lipid rafts, in the cytosol and in lipid rafts, respectively. (B) NCAM140 clustering induces palmitoylation of the intracellular 
domain of NCAM140 that promotes NCAM140 redistribution to lipid rafts, where it binds to prion protein (PrP). In parallel, NCAM140 clustering induces 
FGFR activation, promoting arachidonic acid production (not depicted), which results in arachidonic acid  –  dependent Ca 
2+   inﬂ  ux (  Williams et al., 1994  ) 1197  NCAM ACTIVATES RPTP     VIA CAMKII       • Bodrikov et al. 
PKC     but not other PKC isoforms playing the major role in the 
phosphorylation of RPTP     on Ser180 and Ser204 (  Brandt et al., 
2003  ). However, we found that PKC     is not involved in NCAM-
induced activation. In agreement with this notion is the observa-
tion that 2.5  –  10   μ  M of the PKC     inhibitor rottlerin did not inhibit 
RPTP     serine phosphorylation in nonstimulated NIH3T3 fi  bro-
blasts, and that very high concentrations of rottlerin (50   μ  M) only 
mildly affected RPTP     serine phosphorylation (unpublished data), 
which suggests that other enzymes are involved. Furthermore, we 
show that BisI, a PKC     inhibitor, does not block RPTP   -mediated 
fyn activation in response to NCAM clustering. Accordingly, we 
identifi  ed CaMKII     as a previously unrecognized enzyme that 
binds to and phosphorylates RPTP     at serine residues Ser180 
and Ser204, increasing the phosphatase activity of RPTP   .  We 
also show that CaMKII  , which associates with NCAM via spec-
trin (  Sytnyk et al., 2006  ), is activated in response to clustering of 
NCAM at the cell surface. Calmodulin, which associates with 
RPTP     in the presence of Ca 
2+  , may thus play a role in CaMKII    
activation (  Liang et al., 2000  ). NCAM-induced CaMKII     ac-
tivation then leads to phosphorylation of RPTP     at Ser180 and 
Ser204, which, in turn, leads to activation of lipid raft-enriched 
fyn (  Fig. 10  ). 
  Overexpression of RPTP     in neurons enhances basal neu-
rite outgrowth rates, probably by nonspecifi  c activation of Src-
family kinases. Indeed, overexpression of RPTP   in nonneuronal 
cells results in persistent activation of Src, with concomitant 
cell transformation and tumorigenesis (  Zheng et al., 1992  , 
  2000  ), and mutation of Ser180 or Ser204 blocks neoplastic 
transformation of cells by RPTP     (  Zheng et al., 2002  ). This 
suggests that phosphorylation and activity of RPTP     are tightly 
regulated in normal cells. Homeostatic mechanisms that co-
ordinate changes in RPTP     phosphatase activity are therefore 
intimately linked with the changes in cell behavior. It is thus not 
surprising that disturbance of the relationship of NCAM with 
RPTP     may link NCAM to tumorigenesis in different cell types 
that express NCAM (  Cavallaro and Christofori, 2004a  ,  b  ). 
  Our study again emphasizes the importance of lipid-
enriched microdomains, the so-called lipid rafts. The fact that 
NCAM uses this signaling platform for fyn activation has previ-
ously been shown by ablating the palmitoylation sites in the 
intracellular domain of NCAM, which target the two major trans-
membrane isoforms of NCAM to lipid rafts (  Niethammer et al., 
2002  ). NCAM-dependent fyn activation was also reduced in 
prion protein-defi  cient mice, which correlates with reduced lev-
els of NCAM in lipid rafts isolated from these mice and impli-
cates prion protein as a lipid raft  –  recruiting signal for NCAM 
(  Santuccione et al., 2005  ). In this study, we provide further de-
tails on the molecular interactions induced by NCAM in lipid 
rafts by showing that if the targeting of NCAM140 to lipid rafts 
regulated, neurite outgrowth. A double mutant RPTP  S180/204 
did not promote neurite outgrowth and totally blocked the NCAM-
Fc – induced response ( Fig. 9 B ). Thus, we conclude that CaMKII  -
mediated phosphorylation of Ser180 and Ser204 within the 
RPTP     intracellular domain is required for NCAM-induced 
neurite outgrowth. 
  Discussion 
  In this study, we have further explored the cascades of molecu-
lar interactions activated by the neural cell adhesion molecule 
NCAM; the molecular players in the functional interconnection 
had been previously implicated in NCAM-dependent neurite 
outgrowth. The tyrosine kinase fyn was the fi  rst to be identifi  ed 
as an NCAM-associated signaling partner that triggers the MAP 
kinase/FAK-related downstream signaling of NCAM, leading 
to activation of transcription factors, such as CREB (  Beggs et al., 
1997  ;   Schmid et al., 1999  ;   Jessen et al., 2001  ). The fyn pathway 
then became very important as a cosignaling pathway in NCAM-
induced signaling, which needed to be activated in lipid rafts in 
parallel with the FGF receptor located outside of lipid rafts in 
order to trigger converging signaling cascades to enhance neu-
rite outgrowth (  Niethammer et al., 2002  ). Because the intra-
cellular domain of NCAM does not contain sequences known to 
induce fyn activation, we previously investigated the relation-
ship between NCAM and the well-known activator of Src-family 
tyrosine kinases, of which fyn is a member, the receptor pro-
tein tyrosine phosphatase RPTP   .  RPTP    that dephospho-
rylates Tyr-531 of fyn to activate the enzyme ( Bhandari et al., 1998 ) 
is highly enriched in neurons and growth cones (  Helmke et al., 
1998 ), where it colocalizes with NCAM ( Bodrikov et al., 2005 ). 
We identifi  ed RPTP    as a direct binding partner of NCAM140, 
linking this NCAM isoform to fyn. Interestingly, the interaction 
between NCAM and RPTP     was enhanced by spectrin (  Bodrikov 
et al., 2005  ), which also interacts directly with the intracellular 
domains of the transmembrane isoforms of NCAM, NCAM140, 
and, in particular, NCAM180 (  Pollerberg et al., 1986  ,   1987  ; 
 Sytnyk  et  al., 2002  ;   Leshchyns  ’  ka et al., 2003  ) and indirectly 
via lipid rafts with the GPI-anchored isoform NCAM120 
( Leshchyns ’ ka  et  al.,  2003 ). 
  In this study, we expand our previous fi  ndings by showing 
that clustering of NCAM at the cell surface enhances serine phos-
phorylation and phosphatase activity of RPTP    , thus identifying 
NCAM as the fi  rst recognition molecule and surface receptor that 
not only associates with but also regulates the catalytic activity of 
RPTP    . The catalytic phosphatase activity of RPTP     can be en-
hanced by PKC-mediated Ser180 and/or Ser204 phosphorylation 
of the intracellular domain of RPTP     (  den Hertog et al., 1995  ; 
  Tracy et al., 1995  ;   Stetak et al., 2001  ;   Zheng et al., 2002  ), with 
via T- and L-type VDCC. An increase in Ca 
2+   concentration promotes binding of Ca 
2+  /CaM to CaMKII    , releasing the catalytic domain of CaMKII     from 
inhibition by autoregulatory sequences proximal to the CaM binding site (not depicted). By associating with T- and L-type VDCC, NCAM anchors CaMKII    , 
which is bound to NCAM140 via spectrin, near the Ca 
2+   inﬂ  ux sites. NCAM-induced aggregation of CaMKII     in lipid rafts promotes transautophospho-
rylation of the CaMKII     holoenzymes at Thr286, resulting in the constitutive activation of CaMKII    . (C) In parallel to CaMKII     activation, NCAM140 
promotes redistribution of RPTP     to lipid rafts. In lipid rafts, activated CaMKII     (only one CaMKII     molecule is shown for simplicity) phosphorylates RPTP     
at Ser180 and Ser204, which changes the conformation of RPTP    , resulting in enzyme activation. (D) Activated RPTP     binds and dephosphorylates fyn at 
Tyr531, activating the enzyme. Downstream targets of active fyn include the Ras  –  MAP (MAP) kinase pathway, the sustained activity of which is required 
for neuronal differentiation (not depicted).     
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is disturbed, NCAM-induced activation of CaMKII     in lipid 
rafts and subsequent phosphorylation and activation of RPTP   , 
and thus of fyn, are reduced. Because aggregation and oligomer-
ization of CaMKII     is necessary for full activation of the 
enzyme (  Hudmon et al., 2005  ), we propose that the special en-
vironment of lipid rafts promotes oligomerization of NCAM-
associated CaMKII     to induce its full activation (  Fig. 10  ). 
In agreement, clustering of NCAM increases the levels of detergent-
insoluble oligomerized CaMKII     in cultured hippocampal 
neurons (  Sytnyk et al., 2006  ). Association of NCAM with 
T- and L-type VDCC accumulating in lipid rafts should then 
bring CaMKII     into the vicinity of the sites of Ca 
2+   infl  ux into 
the cell (  Fig. 10  ). Thus, our present study confi  rms the importance 
of lipid rafts in cell signaling for neurite outgrowth. The genera-
tion of such platforms during ontogenetic development appears 
to be crucial for neurite outgrowth. It will be interesting to de-
termine whether such cell adhesion molecule-mediated platforms 
are required for synaptic plasticity in the adult brain, which 
requires functional and structural modifi  cations of synaptic mem-
branes and associated signaling mechanisms. 
  Materials and methods 
  Antibodies and toxins 
  Rabbit polyclonal antibodies against NCAM (for biochemical and immuno-
cytochemical experiments;   Niethammer et al., 2002  ) and rat monoclonal 
antibodies H28 against NCAM (for immunocytochemical experiments; 
  Gennarini et al., 1984  ) were against the extracellular domain of all NCAM 
isoforms. Rabbit antibodies against RPTP     (  den Hertog et al., 1994  ) and 
CHL1 (  Leshchyns  ’  ka et al., 2006  ) were generated as described previously. 
Mouse monoclonal antibodies against PI(4,5)P2 were obtained from 
K. Fukami (University of Tokyo, Tokyo, Japan). Cholera toxin B subunit tagged 
with biotin to label GM1, rabbit polyclonal antibodies against the HA tag, 
L-type VDCC (      1C   subunit), T-type VDCC (      1H   subunit), and CaMKII     were 
obtained from Sigma-Aldrich. Rabbit polyclonal and mouse monoclonal 
antibodies against p59 
fyn   protein were obtained from Santa Cruz Bio-
technology, Inc. Rabbit polyclonal antibodies against Tyr527-dephos-
phorylated or Tyr416-phosphorylated pp60 
c-Src   kinase that cross-react 
with Tyr531-dephosphorylated or Tyr420-phosphorylated p59 
fyn  , against 
Thr505-phosphorylated PKC    , and against Thr286-phosphorylated CaMKII     
were obtained from Cell Signaling Technology. Mouse monoclonal anti-
bodies recognizing phosphorylated serine residues were obtained from 
QIAGEN, mouse monoclonal antibodies against PKC     were obtained from 
BD Biosciences, rat monoclonal antibodies against GAPDH were obtained 
from Millipore, and mouse monoclonal antibodies against CaMKII     were 
obtained from Assay Designs. Secondary antibodies against rabbit, rat, 
and mouse Ig coupled to HRP, Cy2, Cy3, or Cy5; and nonspeciﬁ  c rab-
bit, rat, and mouse immunoglobulins (IgG) were obtained from Dianova 
(Hamburg, Germany). 
  Animals 
  Wild-type 0  –  4-d-old C57BL/6J mice were used and compared when indi-
cated to age-matched NCAM    /     mice provided by H. Cremer (Develop-
mental Biology Institute of Marseille, Marseille, France;   Cremer et al., 1994  ) 
and inbred for at least nine generations onto the C57BL/6J background. 
  Cultures of hippocampal and cortical neurons 
  Cultures of hippocampal neurons (for immunocytochemistry, cell ELISA, 
and neurite outgrowth assay) and cortical neurons (for Western blot analy-
sis) were prepared from 1  –  3-d-old mice. Neurons were grown in the presence 
of 10% horse serum on glass coverslips coated with 100   μ  g/ml poly-
  L  -lysine (  Sytnyk et al., 2002  ,   2006  ). 
  Clustering of NCAM at the neuronal cell surface 
  NCAM was clustered at the neuronal surface using NCAM-Fc, rat mono-
clonal (clone H28), or rabbit polyclonal antibodies against the extracellu-
lar domain of NCAM. Application of these three agents produced similar 
levels of fyn activation in cultured neurons and ﬁ  broblasts cotransfected 
with NCAM140 and RPTP    WT (  Figs. 5   and S4, available at http://www
.jcb.org/cgi/content/full/jcb.200803045/DC1). 8   μ  g/ml NCAM-Fc and 
8   μ  g/ml of human Fc, or 10   μ  g/ml NCAM polyclonal antibodies and 
10   μ  g/ml nonspeciﬁ  c rabbit IgG were applied to live neurons in the culture 
medium for 10 min in a CO  2   incubator. Rat monoclonal antibodies H28 or 
10   μ  g/ml nonimmune rat IgG were applied to live neurons for 15 min and 
clustered by secondary antibodies applied for 5 min, followed by washing 
for 5 min, all in a CO  2   incubator. We have found that with this protocol, 
fyn and CaMKII     were activated within 5 min after secondary antibody 
application, and levels of active fyn and CaMKII     reached a plateau 
within 10 min after secondary antibody application (Fig. S5). When indi-
cated, 10   μ  M of the CaMKII     inhibitor KN62 (Merck   &   Co., Inc.) or 0.5   μ  M 
of the PKC inhibitor BisI was applied 1 h before stimulation with antibodies 
or NCAM-Fc. 10   μ  M nifedipine and 5   μ  M pimozide (both from Alomone 
Laboratories Ltd.) were applied for 10 min before stimulation. 
  DNA constructs 
  NCAM140 and NCAM180 constructs were provided by P. Maness (Uni-
versity of North Carolina at Chapel Hill School of Medicine, Chapel Hill, 
NC). NCAM120 was provided by E. Bock (Institute of Molecular Pathol-
ogy, University of Copenhagen, Copenhagen, Denmark). NCAM140    cys 
was as described previously (  Niethammer et al., 2002  ). The plasmid en-
coding the intracellular domain of RPTP     was a gift from C.J. Pallen (Uni-
versity of British Columbia, Vancouver, Canada). N-terminally HA-tagged 
full length RPTP     was used as described previously (  den Hertog and Hunter, 
1996  ;   Blanchetot and den Hertog, 2000  ;   Buist et al., 2000  ). HA-tagged 
RPTP    S180A, RPTP    S204A, and RPTP    S180/204A were generated by 
PCR-mediated site-directed mutagenesis using the following oligonucle-
otides: 5    -AGTCATTCCAACGCTTTCCGCCTGTCA-3     for S180A and 
5    -G    CCAGGTCCCCAGCCACCAACAGGAAG-3     for S204A. The con-
structs were veriﬁ  ed by sequencing. 
  Neurite outgrowth assay 
  Neurite outgrowth was assayed as described previously (  Niethammer et al., 
2002  ). When indicated, neurons were cotransfected with GFP (Clontech 
Laboratories, Inc.) and wild-type or mutated RPTP     constructs 6 h after plat-
ing using Lipofectamine 2000 (Invitrogen) according to the manufacturer  ’  s 
instructions. For nontransfected neurons, 8   μ  g/ml NCAM-Fc (  Chen et al., 
1999  ) or 8   μ  g/ml human Fc (Dianova) were applied immediately after 
plating together with or without 10   μ  M KN62. For transfected neurons, 
NCAM-Fc or Fc were applied 6 h after transfection. Neurons were ﬁ  xed 
24 h after NCAM-Fc and Fc application. Lengths of neurites were mea-
sured using ImageJ software (National Institutes of Health). 
  Immunoﬂ  uorescence labeling 
  In the indicated experiments, NCAM was clustered at the neuronal surface, 
with antibodies against the extracellular domain of NCAM applied to live 
neurons for 15 min and clustered/visualized by secondary antibodies ap-
plied for 5 min followed by washing for 5 min, all in a CO  2   incubator. In 
control experiments, we veriﬁ  ed that application of nonspeciﬁ  c IgG does not 
induce NCAM clustering or redistribution of NCAM-associated proteins. 
When indicated, before ﬁ  xation, neurons were also extracted with ice-cold 
1% Triton X-100 as described previously (  Bodrikov et al., 2005  ). Neurons 
were ﬁ  xed in 4% formaldehyde in PBS, pH 7.3, for 15 min at room tempera-
ture, washed, permeabilized with 0.25% Triton X-100 in PBS for 5 min, and 
blocked in 1% BSA in PBS. For extracted neurons, the permeabilization step 
was omitted. Primary antibodies were applied in 1% BSA in PBS for 2 h at 
room temperature and detected with corresponding secondary antibodies 
applied for 45 min in 1% BSA in PBS at room temperature. 
  Image acquisition and manipulation 
  We used Cy2, Cy3, or Cy5 ﬂ  uorochromes. Coverslips were embedded in 
Aqua-Poly/Mount (Polysciences, Inc.). For neurite outgrowth measure-
ments, images of neurons were acquired at room temperature using a mi-
croscope (Axiophot 2) equipped with a digital camera (AxioCam HRc), 
AxioVision software (version 3.1), and a Plan-Neoﬂ  uar 40  ×   objective 
(numerical aperture 0.75; all from Carl Zeiss, Inc.). Immunoﬂ  uorescence 
images were acquired at room temperature using a confocal laser scan-
ning microscope (LSM510), LSM510 software (version 3) and an oil Plan-
Neoﬂ  uar 40  ×   objective (numerical aperture 1.3; all from Carl Zeiss, Inc.) 
at 3  ×   digital zoom. Contrast and brightness of the images were further 
adjusted in Corel Photo-Paint 9 (Corel Corporation). 
  Immunoﬂ  uorescence quantiﬁ  cation 
  Proﬁ  les of distributions of the immunoﬂ  uorescence signals along neu-
rites were obtained using ImageJ software, then used to calculate mean 1199  NCAM ACTIVATES RPTP     VIA CAMKII       • Bodrikov et al. 
supplemented with 200   μ  M ATP in the presence of activated CaMKII    , then 
washed with TBS, centrifuged for 1 min, and used for Western blot analysis or 
protein phosphorylation estimation. 
  Estimation of the serine phosphorylation of RPTP     
  Serine/threonine phosphorylation was analyzed by the alkaline hydrolysis 
of phosphate from seryl and threonyl residues in phosphoproteins. Because 
mutations of Ser180 and Ser204 within RPTP    -ID completely inhibited ser-
ine/threonine phosphorylation of RPTP    , we refer to this method as to the 
analysis of serine phosphorylation of RPTP     throughout the text. In brief, 
beads containing phosphorylated and control proteins were treated with 
1 N NaOH for 30 min at 65  °  C. The reaction was stopped by the addition 
of a similar volume of 3.1 N HCl, and released phosphate was measured 
using Malachite green phosphate detection kit (R  &  D Systems) according to 
manufacturer  ’  s instructions. 
  Analysis of the RPTP     phosphatase activity 
  Control beads and beads with immunoprecipitated RPTP     were washed 
twice with RIPA buffer, three times with TBS, and diluted in TBS. Glutathione 
beads with GST or recombinant RPTP    -ID were washed and diluted in TBS. 
Phosphatase activity was measured using a nonradioactive phosphatase 
assay system (Promega) according to manufacturer  ’  s instructions. 
  Gel electrophoresis and immunoblotting 
  Proteins were separated by 8% SDS-PAGE and electroblotted onto nitro-
cellulose transfer membrane (PROTRAN; Sigma-Aldrich) overnight at 5 mA. 
Immunoblots were blocked in milk and incubated with appropriate primary 
antibodies followed by incubation with peroxidase-labeled secondary anti-
bodies and visualized using Super Signal West Pico reagents (Thermo 
Fisher Scientiﬁ  c) on BIOMAX ﬁ  lm (Sigma-Aldrich). For immunoblots labeled 
with phospho-speciﬁ  c antibodies, 3% of BSA was used instead of milk. 
Molecular weight markers were prestained protein standards from Bio-Rad 
Laboratories. For quantitative comparisons of chemiluminescence between 
the lanes, the same amounts of total protein or equal amounts of immuno-
precipitates were loaded in each lane. All preparations were performed 
three times and at least two Western blots were performed with an indi-
vidual sample (  n     ≥   6). Values from all Western blots were used to calculate 
mean values and standard errors of the mean. The chemiluminescence 
quantiﬁ   cation was performed using TINA 2.09 software (University of 
Manchester) or Scion Image for Windows (Scion Corporation). Group 
comparisons were made using a paired   t   test. 
  Online supplemental material 
  Fig. S1 shows the analysis of the Ser180 and Ser204 phosphorylation 
and phosphatase activity of RPTP    WT, expressed in RPTP    -negative ﬁ  bro-
blasts alone or together with NCAM120 or NCAM180, after application 
of NCAM polyclonal antibodies or nonspeciﬁ  c rabbit IgG to transfected 
ﬁ  broblasts. Fig. S2 shows the analysis of the RPTP    WT phosphorylation 
and CaMKII    , PKC    , and fyn activation in CHO cells that were cotrans-
fected with RPTP    WT and NCAM120, NCAM140, NCAM180, or GFP 
and treated with NCAM antibodies or nonspeciﬁ   c rabbit IgG. Fig. S3 
shows levels of activated CaMKII     in lipid rafts from NCAM+/+ and 
NCAM    /     brains, and provides the analysis of the inﬂ   uence of lipid 
raft disruption by methyl-    -cyclodextrin on CaMKII     activation and RPTP     
phosphorylation and activation in NCAM140-transfected CHO cells. Fig. S4 
contains a comparison of the effects of NCAM clustering by polyclonal 
or monoclonal antibodies against the extracellular domain of NCAM or 
by NCAM-Fc on fyn activation in RPTP    -negative ﬁ  broblasts cotransfected 
with NCAM140 and RPTP    WT. Fig. S5 shows the time course of NCAM-
dependent fyn and CaMKII     activation in dissociated hippocampal neu-
rons treated with NCAM monoclonal antibodies or nonspeciﬁ  c rat IgG. 
Online supplemental material is available at http://www.jcb.org/cgi/
content/full/jcb.200803045/DC1. 
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immunoﬂ  uorescence intensities along neurites and to analyze coefﬁ  cients 
of correlation between distributions of the Thr286-phosphorylated CaMKII     
and PI(4,5)P2. 
  Cultures and transfection of CHO cells and ﬁ  broblasts 
  CHO cells and ﬁ  broblasts were maintained in Glasgow or Dulbecco  ’  s 
modiﬁ  ed Eagle  ’  s medium, respectively, containing 10% of fetal calf se-
rum. Cells were transfected using Lipofectamine and Plus reagent (Invitrogen) 
according to the manufacturer  ’  s instruction. When indicated, 10   μ  g/ml 
NCAM polyclonal antibodies or 10   μ  g/ml nonspeciﬁ  c rabbit IgG were 
applied to cells for 10 min. 10   μ  M KN62 was applied 1 h before stimula-
tion, and NCAM antibodies were applied (as described in the Clustering 
of NCAM at the neuronal cell surface section) but in the presence of 
KN62. To deplete cholesterol from lipid rafts, cultures were incubated for 
15 min with 5 mM methyl-    -cyclodextrin (MCD; Sigma-Aldrich) before 
stimulation, and NCAM antibodies were applied (as described in the 
Clustering of NCAM at the neuronal cell surface section) but in the pres-
ence of MCD. All reagents were applied in culture medium at 37  °  C in a 
CO  2   incubator. 
  Immunoprecipitation and coimmunoprecipitation 
  Brain homogenates were prepared using 50 mM Tris-HCl buffer, pH 7.5, 
containing 1 mM CaCl  2  , 1 mM MgCl  2  , and 1 mM NaHCO  3  . Samples 
containing 1 mg of total protein were lysed for 40 min on ice with RIPA 
buffer (50 mM Tris-HCl buffer, pH 7.5, containing 150 mM NaCl, 1% 
Nonidet P-40, 0.5% deoxycholate, 1 mM Na  2  P  2  O  7  , 1 mM NaF, 2 mM 
NaVO  4  , 0.1 mM PMSF, and EDTA-free protease inhibitor cocktail [Roche]). 
In experiments with transiently transfected CHO cells, cells were washed 
twice with ice-cold PBS and lysed 30 min on ice with RIPA buffer. After 
centrifugation, supernatants were cleared with protein A/G  –  agarose 
beads (Santa Cruz Biotechnology, Inc.) for 3 h at 4  °  C, then incubated with 
corresponding antibodies or control IgG for 1.5 h at 4  °  C followed by 
precipitation with protein A/G  –  agarose beads for 1 h at 4  °  C. The beads 
were washed three times with RIPA buffer and twice with PBS, then ana-
lyzed by immunoblotting. 
  Isolation of cytosolic, total membrane, and lipid raft fractions 
  Brain homogenates were prepared using a Potter homogenizer in HOMO 
buffer (1 mM MgCl  2  , 1 mM CaCl  2  , 1 mM NaHCO  3  , and 5 mM Tris, pH 7.4) 
containing 0.32 M sucrose (HOMO-A) and centrifuged at 700   g   for 10 min 
at 4  °  C to pellet nuclei and mitochondria. The resulted supernatants were 
centrifuged at 100,000   g   at 4  °  C for 30 min. Supernatants obtained after 
centrifugation were used as fractions enriched in cytosolic proteins, whereas 
pellets were used as total membrane fractions. Rafts were isolated from total 
membrane fractions as described previously (  Leshchyns  ’  ka et al., 2003  ). 
In brief, membranes were resuspended in ice-cold TBS, pH 7.5, and ex-
tracted for 20 min on ice with 4 volumes of 1% Triton X-100 in TBS. Extracted 
membranes were mixed with equal volume of 80% sucrose in 0.2 M sodium 
carbonate, overlaid sequentially with 30% sucrose in TBS, 10% sucrose in 
TBS, and TBS, and centrifuged at 230,000   g   for 17 h at 4  °  C. The lipid raft 
fraction was collected at the interface between 10 and 30% sucrose, pel-
leted by centrifugation at 100,000   g   for 1 h at 4  °  C, and resuspended in 
TBS. Total protein concentration was measured using the BC kit (Interchim). 
  Recombinant proteins 
  Human Fc-tagged extracellular domain of mouse NCAM and GST-tagged 
intracellular domains of RPTP     were used as described previously (  Chen 
et al., 1999  ;   Bodrikov et al., 2005  ). Calmodulin-dependent protein kinase 
II     (CaMKII    ) was obtained from New England Biolabs, Inc. 
  In vitro phosphorylation 
  Recombinant CaMKII    or CaMKII    immunopuriﬁ  ed from rat brain (BIOMOL 
International, L.P.) was activated according to the manufacturer  ’  s instruc-
tions. For analysis of the phosphorylation in vitro, proteins were immuno-
precipitated from CHO cells, ﬁ   broblasts, or brain homogenates as 
described in the Immunoprecipitation and coimmunoprecipitation section. 
Mock immunoprecipitation with nonspeciﬁ  c IgG served as a control of 
immunoprecipitation speciﬁ  city, and beads with immunoprecipitated non-
speciﬁ  c IgG obtained after mock immunoprecipitation were used as control 
in phosphorylation reactions. Beads were then washed twice with RIPA buf-
fer, three times with TBS, and diluted in TBS. To analyze phosphorylation of 
recombinant RPTP    -ID, they were coupled to glutathione beads. Glutathi-
one beads with GST coupled instead of RPTP    -ID were used as control. 
Beads were washed three times with TBS and diluted in TBS. Equal volumes 
of control beads or beads with proteins of interest were incubated for 
30 min at 30  °  C in CaMKII     reaction buffer (New England Biolabs, Inc.) JCB • VOLUME 182 • NUMBER 6 • 2008  1200
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